0000899243-23-020425.txt : 20231117 0000899243-23-020425.hdr.sgml : 20231117 20231117160519 ACCESSION NUMBER: 0000899243-23-020425 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231117 FILED AS OF DATE: 20231117 DATE AS OF CHANGE: 20231117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Michaud Charles Jr CENTRAL INDEX KEY: 0001999011 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38433 FILM NUMBER: 231418581 MAIL ADDRESS: STREET 1: C/O HOMOLOGY MEDICINES, INC. STREET 2: ONE PATRIOTS PARK CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Homology Medicines, Inc. CENTRAL INDEX KEY: 0001661998 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473468154 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PATRIOTS PARK CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 781-301-7277 MAIL ADDRESS: STREET 1: ONE PATRIOTS PARK CITY: BEDFORD STATE: MA ZIP: 01730 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-11-17 0 0001661998 Homology Medicines, Inc. FIXX 0001999011 Michaud Charles Jr C/O HOMOLOGY MEDICINES, INC. ONE PATRIOTS PARK BEDFORD MA 01730 0 1 0 0 See Remarks Common Stock 2112 D Employee Stock Option (Right to Buy) 15.58 2030-07-08 Common Stock 25000 D Employee Stock Option (Right to Buy) 13.91 2031-02-16 Common Stock 9800 D Employee Stock Option (Right to Buy) 2.71 2032-02-24 Common Stock 19300 D Employee Stock Option (Right to Buy) 1.60 2033-02-23 Common Stock 49000 D Restricted Stock Units Common Stock 544 D Restricted Stock Units Common Stock 2144 D Restricted Stock Units Common Stock 8000 D The option vests or has vested as to 25% of the underlying shares on June 8, 2021 and in 36 substantially equal monthly installments upon the Reporting Person's completion of each full month of service thereafter so that such option will become fully vested on June 8, 2024. The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2021 such that the option will become fully vested on January 1, 2025. The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2022 so that such option will become fully vested on January 1, 2026. The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2023 so that such option will become fully vested on January 1, 2027. The restricted stock units will vest and settle in full on January 1, 2024. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. The restricted stock units will vest and settle as to 1,056 shares on January 1, 2024 and 1,088 shares on January 1, 2025. The restricted stock units will vest and settle as to one-third of the restricted stock units on each of the first three anniversaries of January 1, 2023. Exhibit 24 - Power of Attorney. Vice President, Corporate Controller and Treasurer /s/ Paul Alloway, Attorney-in-Fact for Charles Michaund, Jr. 2023-11-17 EX-24 2 attachment1.htm EX-24 DOCUMENT
                                                                      EXHIBIT 24

                               POWER OF ATTORNEY

With respect to holdings of and transactions in securities issued by Homology
Medicines, Inc. (the "Company"), the undersigned hereby constitutes and appoints
the individuals named on Schedule A attached hereto and as may be amended from
time to time, or any of them signing singly, with full power of substitution and
resubstitution, to act as the undersigned's true and lawful attorney-in-fact to:

     1.   prepare, execute in the undersigned's name and on the undersigned's
          behalf, and submit to the United States Securities and Exchange
          Commission (the "SEC") a Form ID, including amendments thereto, and
          any other documents necessary or appropriate to obtain and/or
          regenerate codes and passwords enabling the undersigned to make
          electronic filings with the SEC of reports required by Section 16(a)
          of the Securities Exchange Act of 1934, as amended, or any rule or
          regulation of the SEC;

     2.   execute for and on behalf of the undersigned, Forms 3, 4, and 5 in
          accordance with Section 16 of the Securities Exchange Act of 1934, as
          amended, and the rules thereunder;

     3.   do and perform any and all acts for and on behalf of the undersigned
          which may be necessary or desirable to complete and execute any such
          Form 3, 4, or 5, complete and execute any amendment or amendments
          thereto, and timely file such form with the SEC and any stock exchange
          or similar authority; and

     4.   take any other action of any type whatsoever in connection with the
          foregoing which, in the opinion of such attorney-in-fact, may be of
          benefit to, in the best interest of, or legally required by, the
          undersigned, it being understood that the documents executed by such
          attorney-in-fact on behalf of the undersigned pursuant to this Power
          of Attorney shall be in such form and shall contain such terms and
          conditions as such attorney-in-fact may approve in such
          attorney-in-facts discretion.

The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution and
resubstitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted.

The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are not assuming, nor is any
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934, as amended.

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 27th day of October, 2023.

                                   By:    /s/ Charles Michaud, Jr.
                                          ------------------------
                                   Name:  Charles Michaud, Jr.


                                   Schedule A

     Individuals Appointed as Attorney-in-Fact with Full Power of Substitution
and Resubstitution

1.   Paul Alloway